Allosteric regulation of fibronectin binding by the anti-β1 integrin antibody TS2/16
The monoclonal antibody (mAb) TS2/16 stabilizes the active conformation of β1 integrin, enhancing its adhesive capacity on the cell surface. However, the molecular mechanism by which TS2/16 modulates integrin affinity for extracellular ligands remains unclear. Using endogenous full-length α5β1 integrin purified from human placenta, we determined the structure of integrin α5β1 with fibronectin up to 2.61-Å resolution in the absence of TS2/16, capturing the active form without its aid, and performed comparative B-factor-based analysis and CABS-Flex simulation with and without TS2/16. Despite no global conformational differences, we found that TS2/16 interacts with α2 helix of the integrin β1 subunit and contacts the C-terminus of α3 helix, leading to a localized decrease in B factor. This interaction allosterically alters the dynamics of α2-α3 loop despite not being in direct contact with TS2/16. Notably, this loop directly engages fibronectin, and its dynamic change underlies the enhanced ligand-binding affinity and explains increased cell adhesion observed with TS2/16. These findings reveal an allosteric mechanism of integrin regulation by TS2/16 and offer insights for the rational design of therapeutic antibodies targeting integrin-mediated adhesion in pathological contexts such as inflammation and cancer.
Authors
- Christian Biertümpfel (ORCID: https://orcid.org/0000-0002-7528-6547)
- Dalia A. Fantini (ORCID: https://orcid.org/0009-0002-7569-9162)
- Stephanie Schumacher (ORCID: https://orcid.org/0000-0002-4113-1723)
- Jienyu Ding (ORCID: https://orcid.org/0009-0004-0494-2174)
- Dirk Dedden (ORCID: https://orcid.org/0000-0003-3630-1270)
- Naoko Mizuno
Institutions
- National Heart, Lung, and Blood Institute (US)
- Max Planck Institute of Biochemistry (DE)
Publication Details
- Journal
- PNAS Nexus
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1093/pnasnexus/pgag044
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- NHLBI Division of Intramural Research